Corning (NYSE: GLW) recently reported its Q2 results, with revenues and earnings aligning with the street estimates. The company reported Read More
Microsoft’s stock (NASDAQ: MSFT) has gained approximately 12% YTD as compared to the 14% rise in the S&P500 index Read More
The U.S. Commerce Department is anticipated to propose a ban on Chinese software in autonomous and connected vehicles in Read More
Warren Buffett’s Berkshire Hathaway (BRK.A) has significantly reduced its Apple (AAPL) stake, selling about half its shares while Read More
Being a leading company does not mean you will remain there. Once giants in their domains, Nokia, Kodak, and Blackberry Read More
Traders work on the floor of the New York Stock Exchange during afternoon trading on August 02, 2024 in New York City. Read More
“Buy low and sell high.” That’s the cardinal rule of investing. The only problem is that you don’t Read More
As Kamala Harris begins her presidential campaign, she outlines her policies and priorities and discusses the change she would bring Read More
When retirement planning with a spouse, you may be banking on the fact that both of you will collect your Read More
The artificial intelligence (AI) revolution has hit a speed bump. On June 25, 2024, Goldman Sachs released a thought-provoking research report titled “Read More
Dell Technologies (NYSE:DELL) has cemented its status as a leading force in the technology sector with its IT hardware, Read More
Tesla’s (NASDAQ:TSLA) second-quarter financial results confirmed that the electric vehicle maker’s fortunes are fading fast, making now Read More
Below is Validea’s guru fundamental report for PDD HOLDINGS INC – ADR (PDD). Of the 22 guru strategies we follow, PDD Read More
Not long after ChatGPT was released, pundits began warning people that an AI bubble was forming.Read More
How much does Warren Buffett like dividends? We shouldn’t draw any conclusions from the fact that Berkshire Hathaway doesn’Read More
Industry insiders often have perspectives that are invaluable for investors to learn. In that vein, AstraZeneca’s (NASDAQ: AZN) CEO, Read More